Osaic Holdings
IONS icon

Osaic Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Osaic Holdings’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
14,800
+6,090
+70% +$458K ﹤0.01% 2847
2026
Q1 		$654K Sell
8,710
-2,936
-25% -$232K ﹤0.01% 3100
2025
Q4 		$921K Buy
11,646
+1,479
+15% +$111K ﹤0.01% 2782
2025
Q3 		$618K Buy
10,167
+4,871
+92% +$238K ﹤0.01% 3254
2025
Q2 		$209K Buy
5,296
+2,923
+123% +$95.7K ﹤0.01% 3903
2025
Q1 		$71.6K Sell
2,373
-1,613
-40% -$52.8K ﹤0.01% 4437
2024
Q4 		$99K Sell
3,986
-12,386
-76% -$463K ﹤0.01% 4180
2024
Q3 		$656K Buy
16,372
+1,680
+11% +$78.2K ﹤0.01% 2624
2024
Q2 		$700K Buy
14,692
+66
+0.5% +$2.71K ﹤0.01% 2481
2024
Q1 		$634K Sell
14,626
-4,284
-23% -$204K ﹤0.01% 2748
2023
Q4 		$956K Buy
18,910
+7,462
+65% +$357K ﹤0.01% 2564
2023
Q3 		$519K Buy
11,448
+2,687
+31% +$111K ﹤0.01% 3210
2023
Q2 		$360K Sell
8,761
-774
-8% -$29.7K ﹤0.01% 3433
2023
Q1 		$341K Sell
9,535
-1,294
-12% -$48.6K ﹤0.01% 3435
2022
Q4 		$408K Sell
10,829
-706
-6% -$29.7K ﹤0.01% 3211
2022
Q3 		$510K Sell
11,535
-5,889
-34% -$248K ﹤0.01% 2871
2022
Q2 		$646K Sell
17,424
-2,142
-11% -$80.8K ﹤0.01% 2682
2022
Q1 		$728K Buy
19,566
+419
+2% +$13.7K ﹤0.01% 2865
2021
Q4 		$583K Buy
19,147
+706
+4% +$22.2K ﹤0.01% 2916
2021
Q3 		$619K Sell
18,441
-2,462
-12% -$92.8K ﹤0.01% 2819
2021
Q2 		$833K Buy
20,903
+4,937
+31% +$193K ﹤0.01% 2521
2021
Q1 		$720K Buy
15,966
+2,588
+19% +$144K ﹤0.01% 2514
2020
Q4 		$757K Buy
13,378
+794
+6% +$39.6K ﹤0.01% 2278
2020
Q3 		$595K Sell
12,584
-2,097
-14% -$116K ﹤0.01% 2276
2020
Q2 		$867K Buy
14,681
+1,104
+8% +$61.4K ﹤0.01% 1859
2020
Q1 		$643K Buy
+13,577
New +$757K ﹤0.01% 1866

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Osaic Holdings's IONS Position: Q2 2026 in Review

Osaic Holdings increased its Ionis Pharmaceuticals (IONS) stake by 70% in Q2 2026, buying an estimated $458K and bringing the position to 14,800 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2847.

Osaic Holdings first reported a position in IONS in Q1 2020 and has held it in 26 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Osaic Holdings held 14,800 shares of Ionis Pharmaceuticals worth $1.17M as of Q2 2026.
  • Osaic Holdings bought 6,090 Ionis Pharmaceuticals shares in Q2 2026, an estimated $458K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2847 holding.
  • Osaic Holdings first reported a position in Ionis Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.